These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
434 related articles for article (PubMed ID: 19335534)
1. Prevalence of diabetic peripheral neuropathy and relation to glycemic control therapies at baseline in the BARI 2D cohort. Pop-Busui R; Lu J; Lopes N; Jones TL; J Peripher Nerv Syst; 2009 Mar; 14(1):1-13. PubMed ID: 19335534 [TBL] [Abstract][Full Text] [Related]
2. Impact of glycemic control strategies on the progression of diabetic peripheral neuropathy in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Cohort. Pop-Busui R; Lu J; Brooks MM; Albert S; Althouse AD; Escobedo J; Green J; Palumbo P; Perkins BA; Whitehouse F; Jones TL; Diabetes Care; 2013 Oct; 36(10):3208-15. PubMed ID: 23757426 [TBL] [Abstract][Full Text] [Related]
3. Relation of severe coronary artery narrowing to insulin or thiazolidinedione use in patients with type 2 diabetes mellitus (from the Bypass Angioplasty Revascularization Investigation 2 Diabetes Study). Pop-Busui R; Lombardero M; Lavis V; Forker A; Green J; Korytkowski M; Sobel BE; Jones TL; Am J Cardiol; 2009 Jul; 104(1):52-8. PubMed ID: 19576321 [TBL] [Abstract][Full Text] [Related]
4. [Revascularization in patients with type 2 diabetes and coronary artery disease: BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) Study Group]. Störk S; Ertl G; Nitschmann S Internist (Berl); 2010 May; 51(5):674-6. PubMed ID: 20352177 [No Abstract] [Full Text] [Related]
5. Baseline characteristics of patients with diabetes and coronary artery disease enrolled in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial. Bypass Angioplasty Revascularization Investigation 2 Diabetes Study Group Am Heart J; 2008 Sep; 156(3):528-536, 536.e1-5. PubMed ID: 18760137 [TBL] [Abstract][Full Text] [Related]
6. Profibrinolytic, antithrombotic, and antiinflammatory effects of an insulin-sensitizing strategy in patients in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial. Sobel BE; Hardison RM; Genuth S; Brooks MM; McBane RD; Schneider DJ; Pratley RE; Huber K; Wolk R; Krishnaswami A; Frye RL; Circulation; 2011 Aug; 124(6):695-703. PubMed ID: 21768545 [TBL] [Abstract][Full Text] [Related]
7. HbA1c variability and diabetic peripheral neuropathy in type 2 diabetic patients. Su JB; Zhao LH; Zhang XL; Cai HL; Huang HY; Xu F; Chen T; Wang XQ Cardiovasc Diabetol; 2018 Mar; 17(1):47. PubMed ID: 29598819 [TBL] [Abstract][Full Text] [Related]
8. The BARI 2D study: a randomised trial of therapies for type 2 diabetes and coronary artery disease. Rutter MK; Nesto RW Diab Vasc Dis Res; 2010 Jan; 7(1):69-72. PubMed ID: 20368235 [TBL] [Abstract][Full Text] [Related]
9. Combination therapy with insulin glargine plus metformin but not insulin glargine plus sulfonylurea provides similar glycemic control to triple oral combination therapy in patients with type 2 diabetes uncontrolled with dual oral agent therapy. Hollander P; Sugimoto D; Vlajnic A; Kilo C J Diabetes Complications; 2015; 29(8):1266-71. PubMed ID: 26281972 [TBL] [Abstract][Full Text] [Related]
10. Diabetic peripheral neuropathy: age-stratified glycemic control. Wang CS; Pai YW; Lin CH; Lee IT; Chen HH; Chang MH Front Endocrinol (Lausanne); 2024; 15():1377923. PubMed ID: 38694945 [TBL] [Abstract][Full Text] [Related]
11. Peripheral neuropathy in adolescents and young adults with type 1 and type 2 diabetes from the SEARCH for Diabetes in Youth follow-up cohort: a pilot study. Jaiswal M; Lauer A; Martin CL; Bell RA; Divers J; Dabelea D; Pettitt DJ; Saydah S; Pihoker C; Standiford DA; Rodriguez BL; Pop-Busui R; Feldman EL; Diabetes Care; 2013 Dec; 36(12):3903-8. PubMed ID: 24144652 [TBL] [Abstract][Full Text] [Related]
12. Prevalence of and Risk Factors for Diabetic Peripheral Neuropathy in Youth With Type 1 and Type 2 Diabetes: SEARCH for Diabetes in Youth Study. Jaiswal M; Divers J; Dabelea D; Isom S; Bell RA; Martin CL; Pettitt DJ; Saydah S; Pihoker C; Standiford DA; Dolan LM; Marcovina S; Linder B; Liese AD; Pop-Busui R; Feldman EL Diabetes Care; 2017 Sep; 40(9):1226-1232. PubMed ID: 28674076 [TBL] [Abstract][Full Text] [Related]
13. Glycemic variability's impact on painful diabetic peripheral neuropathy in type 2 diabetes patients. Chang KC; Pai YW; Lin CH; Lee IT; Chang MH Sci Rep; 2024 Sep; 14(1):22276. PubMed ID: 39333368 [TBL] [Abstract][Full Text] [Related]
14. A Genetic Locus on Chromosome 2q24 Predicting Peripheral Neuropathy Risk in Type 2 Diabetes: Results From the ACCORD and BARI 2D Studies. Tang Y; Lenzini PA; Pop-Busui R; Ray PR; Campbell H; Perkins BA; Callaghan B; Wagner MJ; Motsinger-Reif AA; Buse JB; Price TJ; Mychaleckyj JC; Cresci S; Shah H; Doria A Diabetes; 2019 Aug; 68(8):1649-1662. PubMed ID: 31127053 [TBL] [Abstract][Full Text] [Related]
15. Long-term sustainability of glycaemic achievements with second-line antidiabetic therapies in patients with type 2 diabetes: A real-world study. Montvida O; Shaw JE; Blonde L; Paul SK Diabetes Obes Metab; 2018 Jul; 20(7):1722-1731. PubMed ID: 29536608 [TBL] [Abstract][Full Text] [Related]
16. Progression to insulin for patients with diabetes mellitus using the Texas Medicaid database. Rascati KL; Richards KM; Lopez D; Cheng LI; Wilson JP Clin Ther; 2011 Dec; 33(12):2016-20. PubMed ID: 22101160 [TBL] [Abstract][Full Text] [Related]
17. Glycaemic control among patients with type 2 diabetes mellitus in seven European countries: findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) study. Alvarez Guisasola F; Mavros P; Nocea G; Alemao E; Alexander CM; Yin D Diabetes Obes Metab; 2008 Jun; 10 Suppl 1():8-15. PubMed ID: 18435669 [TBL] [Abstract][Full Text] [Related]
18. Risk factor control for coronary artery disease secondary prevention in large randomized trials. Farkouh ME; Boden WE; Bittner V; Muratov V; Hartigan P; Ogdie M; Bertolet M; Mathewkutty S; Teo K; Maron DJ; Sethi SS; Domanski M; Frye RL; Fuster V J Am Coll Cardiol; 2013 Apr; 61(15):1607-15. PubMed ID: 23500281 [TBL] [Abstract][Full Text] [Related]
19. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. Turner RC; Cull CA; Frighi V; Holman RR JAMA; 1999 Jun; 281(21):2005-12. PubMed ID: 10359389 [TBL] [Abstract][Full Text] [Related]
20. Prevalence and Risk Factors for Diabetic Peripheral Neuropathy among Patients with Type 2 Diabetes in Saudi Arabia: A Cross-sectional Study. Al Ayed MY; Ababneh M; Robert AA; Al-Musalum M; Sabrery D; Amer M; Al Saeed A; Al Dawish MA Curr Diabetes Rev; 2023; 19(7):e141122210875. PubMed ID: 36380415 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]